SELLAS Life Sciences (SLS) Capital Expenditures (2010 - 2016)
SELLAS Life Sciences' (SLS) quarterly Capital Expenditures came in at -$6000.0 in Q4 2016, down 101.32% year-on-year from $453000.0 in Q1 2016, and down 200.0% on a QoQ basis from $6000.0 in Q1 2016.
SELLAS Life Sciences (SLS) Capital Expenditures (2010 - 2016) Analysis & Trends
SELLAS Life Sciences (SLS) has 6 years of Capital Expenditures data on file, last reported at -$6000.0 in Q4 2016.
- On a quarterly basis, Capital Expenditures fell 101.32% year-over-year to -$6000.0 in Q4 2016; TTM through Sep 2016 was $459000.0, a 410.0% increase from a year earlier, with the FY2015 full-year figure at $534000.0, up 836.84% from the prior year.
- Capital Expenditures for Q4 2016 stood at -$6000.0, down from $6000.0 in the prior quarter.
- Over the last five years, Capital Expenditures for SLS reached as high as $500000.0 in Q1 2015 and fell as low as -$466000.0 in Q2 2015.
- Historically, Capital Expenditures has averaged $38416.7 across 4 years, with a median of $14000.0 in 2014.
- On a YoY basis, Capital Expenditures climbed as much as 4933.33% in 2015 and fell as far as 6757.14% in 2015.
- Year by year, Capital Expenditures stood at -$234000.0 in 2013, then soared by 103.85% to $9000.0 in 2014, then jumped by 4933.33% to $453000.0 in 2015, then plunged by 101.32% to -$6000.0 in 2016.
- Per Business Quant data, the three most recent Capital Expenditures figures were -$6000.0 in Q4 2016, $6000.0 in Q1 2016, and $453000.0 in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | SELLAS Life Sciences | 3.23 Mn | 3.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | -6,000.00 |
| Dec 31, 2016 | -6,000.00 |
| Mar 31, 2016 | 6,000.00 |
| Mar 31, 2016 | 6,000.00 |
| Dec 31, 2015 | 453,000.00 |
| Dec 31, 2015 | 453,000.00 |
| Sep 30, 2015 | 47,000.00 |
| Sep 30, 2015 | 47,000.00 |
| Jun 30, 2015 | -466,000.00 |
| Jun 30, 2015 | -466,000.00 |
| Mar 31, 2015 | 500,000.00 |
| Mar 31, 2015 | 500,000.00 |
| Dec 31, 2014 | 9,000.00 |
| Dec 31, 2014 | 9,000.00 |
| Sep 30, 2014 | 19,000.00 |
| Sep 30, 2014 | 19,000.00 |
| Jun 30, 2014 | 7,000.00 |
| Jun 30, 2014 | 7,000.00 |
| Mar 31, 2014 | 22,000.00 |
| Mar 31, 2014 | 22,000.00 |